Thyroid Disorders Flashcards
Hypothyroidism - Causes
Hypothyroidism: causes
Hypothyroidism affects around 1-2% of women in the UK and is around 5-10 times more common in females than males.
Primary hypothyroidism:
1) Hashimoto’s thyroiditis
- most common cause
- autoimmune disease, associated with IDDM, Addison’s or pernicious anaemia
- may cause transient thyrotoxicosis in the acute phase
- 5-10 times more common in women
2) Subacute thyroiditis (de Quervain’s)
3) Riedel thyroiditis
4) After thyroidectomy or radioiodine treatment
5) Drug therapy (e.g. lithium, amiodarone or anti-thyroid drugs such as carbimazole)
6) Dietary iodine deficiency
Secondary hypothyroidism (rare):
1) From pituitary failure
2) Other associated conditions
Down’s syndrome
Turner’s syndrome
coeliac disease
Thyroid Eye Disease
Thyroid eye disease
Thyroid eye disease affects between 25-50% of patients with Graves’ disease.
Pathophysiology
it is thought to be caused by an autoimmune response against an autoantigen, possibly the TSH receptor → retro-orbital inflammation
the inflammation results in glycosaminoglycan and collagen deposition in the muscles
Prevention
smoking is the most important modifiable risk factor for the development of thyroid eye disease
radioiodine treatment may increase the inflammatory symptoms seen in thyroid eye disease. In a recent study of patients with Graves’ disease around 15% developed, or had worsening of, eye disease. Prednisolone may help reduce the risk
Features
the patient may be eu-, hypo- or hyperthyroid at the time of presentation
exophthalmos
conjunctival oedema
optic disc swelling
ophthalmoplegia
inability to close the eye lids may lead to sore, dry eyes. If severe and untreated patients can be at risk of exposure keratopathy
Management topical lubricants may be needed to help prevent corneal inflammation caused by exposure steroids radiotherapy surgery
IV methylprednisolone is the treatment of choice for moderately severe active Graves’ ophthalmopathy. IV steroids have fewer side effects than oral steroids. If symptoms or vision do not improve then urgent surgical decompression should be considered.
Artificial tear drops are useful for symptomatic relief.
Total thyroidectomy has shown no benefit in the treatment of thyroid eye disease.
Outcomes have been shown to be worse in those patients who smoke, therefore smoking cessation advice should be given.
Monitoring patients with established thyroid eye disease
For patients with established thyroid eye disease the following symptoms/signs should indicate the need for urgent review by an ophthalmologist (see EUGOGO guidelines):
unexplained deterioration in vision
awareness of change in intensity or quality of colour vision in one or both eyes
history of eye suddenly ‘popping out’ (globe subluxation)
obvious corneal opacity
cornea still visible when the eyelids are closed
disc swelling
Thyroid Eye Disease - Example Question
A 24-year-old female presents with one week of progressive and persistent double vision. She reports increasing tiredness at all times of day over the past 2 months and occasional chest tightness associated with palpitations. She has no past medical history. She was also adopted and unaware of any family history. On examination, you find a loss of left eye abduction, right eye upwards gaze, right eye adduction. Systemic examination also reveals bilateral clammy hands and a heart rate of 120 per minute, irregular. Which test is most likely to be diagnostic?
Autoimmune screen > Thyroid function tests CT thorax Anti-acetylcholine receptor antibodies 12 lead ECG
This patient presents with systemic symptoms and a complex ophthalmoplegia, the diagnosis of thyroid eye disease, secondary to Graves disease, is most likely. The important test would be thyroid function tests and also MRI of her orbits, which would almost certainly demonstrate retro-orbital and extraocular muscle inflammation. The severity of the patient’s eye disease needs to be assessed: the most frequently used criteria was developed by the American thyroid association, which spells out helpfully NO SPECS
Class 0 No symptoms or signs
Class I Only signs, no symptoms (lid retraction, stare, lid lag)
Class II Soft tissue involvement
Class III Proptosis
Class IV Extraocular muscle involvement
Class V Corneal involvement
Class VI Sight loss (optic nerve involvement)
Any patient presenting with eye movement weaknesses that cannot be explained by isolated or multiple cranial nerve palsies is called complex ophthalmoplegia. The differentials include myasthenia gravis, mononeuritis multiplex, thyroid eye disease, Kearns-Sayre syndrome, complex progressive external ophthalmoplegia, Miller-Fisher syndrome and botulinum poisoning.
Hypothyroidism - Mx : Key Points
Key points
initial starting dose of levothyroxine should be lower in elderly patients and those with ischaemic heart disease. The BNF recommends that for patients with cardiac disease, severe hypothyroidism or patients over 50 years the initial starting dose should be 25mcg od with dose slowly titrated. Other patients should be started on a dose of 50-100mcg od
following a change in thyroxine dose thyroid function tests should be checked after 8-12 weeks
the therapeutic goal is ‘normalisation’ of the thyroid stimulating hormone (TSH) level. As the majority of unaffected people have a TSH value 0.5-2.5 mU/l it is now thought preferable to aim for a TSH in this range
women with established hypothyroidism who become pregnant should have their dose increased ‘by at least 25-50 micrograms levothyroxine’* due to the increased demands of pregnancy. The TSH should be monitored carefully, aiming for a low-normal value
there is no evidence to support combination therapy with levothyroxine and liothyronine
SE of Thyroxine Therapy
Side-effects of thyroxine therapy hyperthyroidism: due to over treatment reduced bone mineral density worsening of angina atrial fibrillation
Thyroxine - Interactions
Interactions
iron: absorption of levothyroxine reduced, give at least 2 hours apart
Hypothyroidism Mx - Example Question
A 29-year-old woman presentsis referred to the Endocrinology clinic as she has just found out she is pregnant. She was diagnosed with hypothyroidism three years ago and is currently stable on a dose of levothyroxine 75mcg od. She has also been taking folic acid 400mcg od for the past 6 months. Her last bloods taken 6 months ago show the following:
TSH 1.4 mU/l
You request a repeat TSH and free T4 measurement. What is the most appropriate next step?
Decrease levothyroxine to 50mcg od Keep levothyroxine at 75mcg od > Increase levothyroxine to 100mcg od Keep levothyroxine at 75mcg od + increase folic acid to 5mg od Stop levothyroxine until TSH known Female with hypothyroidism → immediately increase levothyroxine and monitor TSH closely
Thyrotoxicosis
Thyrotoxicosis
Graves’ disease accounts for around 50-60% of cases of thyrotoxicosis.
Causes
Graves’ disease
toxic nodular goitre
acute phase of subacute (de Quervain’s) thyroiditis
acute phase of post-partum thyroiditis
acute phase of Hashimoto’s thyroiditis (later results in hypothyroidism)
amiodarone therapy
Investigation
TSH down, T4 and T3 up
thyroid autoantibodies
other investigations are not routinely done but includes isotope scanning
Thyrotoxicosis - Example Question
A 42 year-old man presents to his GP with a 3 month history of increasing anxiety. On further questioning, he has lost 6 kg of weight over the past 2 months and has been experiencing increased bowel movements and diarrhoea.
Blood tests are performed and reveal:
Hb 14.2 g/dL
Platelets 210 * 109/l
WBC 6.9 * 109/l
Thyroid stimulating hormone (TSH) 0.08 mu/l
Free thyroxine (T4) 17.4 pmol/l
Total triiodothyronine (T3) 13.4 nmol/l Normal range (4.0-8.3 nmol/l)
What is the most appropriate treatment?
Reassurance > Carbimazole Radio-iodine Surgery Propranolol
The diagnosis in this scenario is triiodothyronine thyrotoxicosis. A small subset of those patients experiencing thyrotoxicosis (roughly 5%) have isolated triiodothyronine thyrotoxicosis. As with other types of thyrotoxicosis, carbimazole is the main initial treatment for the condition.
Sick Euthyroid Syndrome
Sick euthyroid syndrome
In sick euthyroid syndrome (now referred to as non-thyroidal illness) it is often said that everything (TSH, thyroxine and T3) is low. In the majority of cases however the TSH level is within the normal range (inappropriately normal given the low thyroxine and T3).
Changes are reversible upon recovery from the systemic illness.
Sick Euthyroid Syndrome - Example Question
A 76 year old woman was admitted to hospital after presenting to the Emergency Department with shortness of breath, productive cough and palpitations. A chest x-ray demonstrated a left lower lobe pneumonia and ECG showed atrial fibrillation with a fast ventricular response. Initial management included intravenous antibiotics, intravenous fluids and oral digoxin loading.
Two days after admission, the patient’s condition had significantly improved and she was able to start mobilising on the ward. The palpitations that she had been experiencing at presentation had also ceased. Following review by the Senior House Officer on the ward round, a repeat ECG was requested when demonstrated that the patient had cardioverted back to sinus rhythm. Digoxin therapy was subsequently held.
To investigate for an underlying cause of atrial fibrillation, thyroid function tests were added to blood tests from admission, with results as listed below.
Haemoglobin 125 g / dL White cell count 13.7* 109/l Neutrophils 11.9* 109/l Platelets 351 * 109/l Urea 4.6 mmol / L Creatinine 130 micromol / L Sodium 139 mmol / L Potassium 3.6 mmol / L C-reactive protein 105 mg / L Thyroid stimulating hormone 0.25 microU / L T4 free serum 14.1 pmol / L T3 free serum 7.4 pmol / L
What is the most appropriate next investigation to assess deranged thyroid function tests?
Thyroid ultrasound Thyroid peroxidase antibody levels > Repeat TFT in 6 weeks Thyroid scintiscanning Thyroglobulin antibody levels
Any acute and severe illness may alter thyroid hormone deiodination through the effects of cytokines and result in various changes in levels of TSH, fT3 and fT4. Low TSH levels in hospitalised patients are three times more likely to be due to this effect than to hyperthyroidism.
It is therefore best to avoid thyroid function testing around the time of an acute illness unless there is good clinical evidence of a primary thyroid illness. If TFT remain deranged following recovery from acute illness then further investigation to assess for thyroid disease can be considered.
Amiodarone and The Thyroid Gland
Amiodarone and the thyroid gland
Around 1 in 6 patients taking amiodarone develop thyroid dysfunction
Amiodarone-induced hypothyroidism
The pathophysiology of amiodarone-induced hypothyroidism (AIH) is thought to be due to the high iodine content of amiodarone causing a Wolff-Chaikoff effect*
Amiodarone may be continued if this is desirable
Amiodarone-induced thyrotoxicosis
Amiodarone-induced thyrotoxicosis (AIT) may be divided into two types:
AIT type 1
Pathophysiology = Excess iodine-induced thyroid hormone synthesis
Goitre = Present
Management = Carbimazole or potassium perchlorate
AIT Type 2
Pathophysiology = Amiodarone-related destructive thyroiditis
Goitre = Absent
Management = Corticosteroids
Unlike in AIH, amiodarone should be stopped if possible in patients who develop AIT
*an autoregulatory phenomenon where thyroxine formation is inhibited due to high levels of circulating iodide
Amiodarone and the Thyroid Gland - Example Question
A 64-year-old woman comes to the Emergency department complaining of palpitations at rest, and worsening angina over the past month. She has been treated with amiodarone for the past 3 years for recurrent ventricular tachycardia. She has a blood pressure of 110/70 mmHg, pulse of 95 beats per minute, and a fine tremor. There is no goitre. TSH is suppressed at less than 0.05 U/ml.
You suspect she has amiodarone induced thyrotoxicosis. How best can you determine the underlying pathophysiology?
IL6 level Thyroglobulin level TSH level Duration of amiodarone therapy > Colour flow doppler ultrasonography
Type 1 amiodarone induced thyrotoxicosis is caused by increased production of thyroid hormone, most likely as a result of the excess iodine load administered to the patient as a result of amiodarone treatment. Type 2 amiodarone induced thyrotoxicosis is caused by a destructive thyroiditis. Colour flow doppler ultrasonography needs to be performed by an experienced operator, but is thought to distinguish between the two causes of amiodarone induced thyrotoxicosis around 80% of the time. In patients where the diagnosis is uncertain, radioiodine uptake, (which is low in type 2 disease) my further help differentiating between the two.
Type 2 disease is generally seen later in the time course of amiodarone therapy, although this isn’t an invariable differentiating factor, and data on the usefulness of IL6 and thyroglobulin is conflicting.
TFTs - Thyrotoxicosis (eg Graves)
Thyrotoxicosis (e.g. Graves’ disease)
TSH = Low
Free T4 = High
In T3 thyrotoxicosis the free T4 will be normal
TFTs - Primary Hypothyroidism
Primary hypothyroidism (primary atrophic hypothyroidism) TSH = High Free T4 = Low
TFTs - Secondary Hypothyroidism
Secondary hypothyroidism
TSH = Low
Free T4 = Low
Replacement steroid therapy is required prior to thyroxine
Secondary hypothyroidism is very rare and results in a low TSH and low T4. In these cases, pituitary insufficiency is most likely and therefore an MRI of the gland should be performed.
TFTs - Sick Euthyroid Syndrome
Sick euthyroid syndrome* TSH = Low** T4 = Low Common in hospital inpatients T3 is particularly low in these patients
- now referred to as non-thyroidal illness
- *TSH may be normal in some cases
TFTs - Subclinical Hypothyroidism
Subclinical hypothyroidism
TSH = High
Free T4 = Normal
TFTs - Poor Compliance with Thyroxine
Poor compliance with thyroxine
TSH = High
Free T4 = Normal
TFTs - Steroid Therapy
Steroid therapy
TSH = Low
Free T4 = Normal
Toxic Goitre - Example Question
A 55-year-old female has noticed an enlarging neck lump and comes for review with you. Her TSH is low. Apart from the large goitre, there were no other significant findings on physical examination. What is the best next test to performed?
Anti-TSH antibodies Thyroid US > Thyroid Technetium scan Thyroid nodule biopsy Thyroidectomy
The underlying diagnosis is that of a toxic-goitre (low TSH) due to a toxic adenoma. The concern is always that the goitre may be carcinogenic. To rule carcinogenesis out a thyroid technetium scan can be done. If the technetium scan shows a ‘hot’ nodule, then cancer can be ruled out because it is exceedingly rare that a hot nodule is cancer. Thus an over functioning thyroid nodule is diagnosed.
A toxic adenoma occurs due to somatic mutations of the TSH receptor gene that confers autonomous hyperactivity to that thyroid tissue. It responds will to radioiodine ablation or surgical removal
Thyroid Storm
Thyroid storm
Thyroid storm is a rare but life-threatening complication of thyrotoxicosis. It is typically seen in patients with established thyrotoxicosis and is rarely seen as the presenting feature. Iatrogenic thyroxine excess does not usually result in thyroid storm
Clinical features include: fever > 38.5ºC tachycardia confusion and agitation nausea and vomiting hypertension heart failure abnormal liver function test
Thyroid Storm - Mx
Management
symptomatic treatment e.g. paracetamol
treatment of underlying precipitating event
propranolol
anti-thyroid drugs: e.g. carbimazole/ methimazole or propylthiouracil
Lugol’s iodine
dexamethasone - e.g. 4mg IV qds - blocks the conversion of T4 to T3
Thyroid Storm - First Line Treatment
First line treatment for this medical emergency is carbimazole, corticosteroids and propranolol, although chlorpromazine can be added for severe anxiety.